
Lirafugratinib + LITESPARK011
OncoPharm
00:00
FGFR Inhibitor Hyperphosphatemia And Eye Toxicity
John Bazar compares hyperphosphatemia and retinal pigment epithelial detachment rates, highlighting reduced phosphate toxicity but potentially greater ocular toxicity with lirafugratinib.
Play episode from 01:47
Transcript


